We provide targeted assessments and expert-designed market access strategies to guide through the full product development lifecycle.

By assessing the potential value of your therapy and determining how it could address areas of unmet need, Valid Insight can help you to understand pricing, reimbursement and market access opportunities for your product, and develop pragmatic, realistic, expert-designed market access strategies.

• Market access environment assessments
• Disease area strategy analysis
• Initial forecasting and market access planning
• Pricing and market access simulator*
• Dynamic marketplace strategy
• Patient flow models
• Competitive assessment and tracking
• Phase III evidence requirements
• Value proposition testing
• Licensing evaluations
• Price refinement and validation
• Market access and price strategy
• Negotiation strategy
• Patient access schemes
• Tendering excellence
• Policy and publication support

*Valid Insight proprietary tool providing input to go/no-go decisions and early market access plans

Access to insights from global decision makers
Valid Insight maintains a proprietary payer network including over 1,500 current and former payers, payer/ HTA advisors and clinical key opinion leaders covering all major markets.

These experts are instrumental in supporting our market access work through primary research engagements, dyads, F2F and virtual advisory boards, Delphi panels and clinical expert panels.

We work closely with many former payers, who frequently attend to represent ‘mock payers’ at our negotiation and value challenge workshops—providing realistic ‘sparring partners’ for our clients to test out their negotiation strategies in a safe environment.